[1]
“Determination of ADMET properties of substituted-piperidine-3-carboxamide derivatives with potential use in the treatment of Crohn’s disease”, IJBCh, vol. 18, no. 2, pp. 119–135, Dec. 2025, doi: 10.26577/IJBCh202518211.